Frontier Wealth Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $40K | Hold |
13,099
| – | – | ﹤0.01% | 384 |
|
|
2022
Q1 | $87K | Hold |
13,099
| – | – | ﹤0.01% | 391 |
|
|
2021
Q4 | $109K | Hold |
13,099
| – | – | 0.01% | 412 |
|
|
2021
Q3 | $97K | Hold |
13,099
| – | – | 0.01% | 411 |
|
|
2021
Q2 | $89K | Hold |
13,099
| – | – | 0.01% | 419 |
|
|
2021
Q1 | $135K | Sell |
13,099
-14,000
| -52% | -$144K | 0.01% | 371 |
|
|
2020
Q4 | $190K | Hold |
27,099
| – | – | 0.02% | 360 |
|
|
2020
Q3 | $221K | Hold |
27,099
| – | – | 0.02% | 326 |
|
|
2020
Q2 | $187K | Hold |
27,099
| – | – | 0.02% | 332 |
|
|
2020
Q1 | $129K | Hold |
27,099
| – | – | 0.02% | 271 |
|
|
2019
Q4 | $237K | Hold |
27,099
| – | – | 0.04% | 261 |
|
|
2019
Q3 | $90K | Hold |
27,099
| – | – | 0.01% | 296 |
|
|
2019
Q2 | $134K | Hold |
27,099
| – | – | 0.02% | 290 |
|
|
2019
Q1 | $168K | Hold |
27,099
| – | – | 0.02% | 343 |
|
|
2018
Q4 | $91K | Hold |
27,099
| – | – | 0.01% | 346 |
|
|
2018
Q3 | $176K | Hold |
27,099
| – | – | 0.02% | 366 |
|
|
2018
Q2 | $208K | Hold |
27,099
| – | – | 0.03% | 354 |
|
|
2018
Q1 | $606K | Buy |
+27,099
| New | +$606K | 0.08% | 201 |
|